Education, Research & Positions
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and
Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial Summary A Phase 1 clinical trial investigated the safety and feasibility of intracerebroventricular (ICV) administration of bivalent CAR Read More
